pirfenidone has been researched along with Cicatrix in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (53.33) | 24.3611 |
2020's | 7 (46.67) | 2.80 |
Authors | Studies |
---|---|
Astrakhantsev, AF; Atkova, EL; Fedorov, AA; Krakhovetskiy, NN; Rein, DA | 1 |
Gao, B; Li, X; Ma, Y; Pan, J; Qian, H | 1 |
Ale, T; Kehinde, V; Lavik, E; Liu, S; Wang, HC | 1 |
Aimo, A; Aquaro, GD; Barison, A; Burchielli, S; Emdin, M; Masotti, S; Modena, M; Musetti, V; Passino, C; Pucci, A; Terlizzi, D | 1 |
Chen, J; Huang, Y; Lu, C; Mei, L; Pan, X; Peng, T; Quan, G; Wang, B; Wang, H; Wu, C | 1 |
Barrett, VJ; Brockbank, S; Cruwys, S; Dabbagh, RQ; Genovese, F; Good, RB; Jessen, H; Karsdal, MA; Leeming, DJ; Nanthakumar, CB; Rønnow, SR; Sand, JMB; Sorensen, GL | 1 |
Furushima, S; Kodama, H; Kumai, Y; Miyamaru, S; Nishimoto, K; Toya, Y; Yumoto, E | 1 |
DeLuca, PP; Dorati, R; Leung, KP; Medina, JL | 1 |
Dorati, R; Fourcaudot, AB; Leung, KP; Medina, JL; Sebastian, EA | 1 |
Chen, J; Coleman, JA; Durack, JC; Felsen, D; Fujimori, M; Kodama, H; Solomon, SB; Srimathveeravalli, G; Ueshima, E | 1 |
Kodama, H; Kumai, Y; Miyamaru, S; Nishimoto, K; Onoue, S; Orita, Y; Yamada, T | 1 |
Leask, A | 1 |
Jung, KI; Park, CK | 1 |
Hayden, T | 1 |
Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H | 1 |
1 review(s) available for pirfenidone and Cicatrix
Article | Year |
---|---|
Getting to the heart of the matter: new insights into cardiac fibrosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Arrhythmias, Cardiac; Atrophy; Cicatrix; Connective Tissue Growth Factor; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Humans; Hypoxia; Models, Cardiovascular; Molecular Targeted Therapy; Myocardium; Myofibroblasts; Platelet-Derived Growth Factor; Pyridones; Rats; Signal Transduction; Transforming Growth Factor beta | 2015 |
1 trial(s) available for pirfenidone and Cicatrix
Article | Year |
---|---|
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study.
Topics: Animals; Cicatrix; Fibrosis; Humans; Male; Myocardial Infarction; Rats; Rats, Wistar; Ventricular Remodeling | 2023 |
13 other study(ies) available for pirfenidone and Cicatrix
Article | Year |
---|---|
[Experimental investigation of the efficacy of pirfenidone in prevention of ostium cicatricial closure after dacryocystorhinostomy].
Topics: Animals; Cicatrix; Dacryocystorhinostomy; Endoscopy; Nasolacrimal Duct; Pyridones; Rabbits; Treatment Outcome | 2021 |
Treatment of scarring central airway stenosis with pirfenidone: Case report.
Topics: Bronchi; Bronchoscopy; Cicatrix; Constriction, Pathologic; Humans; Stents; Tomography, X-Ray Computed; Trachea | 2022 |
Polyester Nanoparticles and Polyurethane Nanocapsules Deliver Pirfenidone To Reduce Fibrosis and Scarring.
Topics: Cicatrix; Humans; Inflammation; Nanocapsules; Nanoparticles; Polyesters; Polylactic Acid-Polyglycolic Acid Copolymer; Polyurethanes | 2023 |
A pirfenidone loaded spray dressing based on lyotropic liquid crystals for deep partial thickness burn treatment: healing promotion and scar prophylaxis.
Topics: Animals; Antifibrinolytic Agents; Bandages; Burns; Cells, Cultured; Cicatrix; Disease Models, Animal; Humans; Liquid Crystals; Male; Mice; Mice, Inbred BALB C; Particle Size; Pyridones; Surface Properties; Wound Healing | 2020 |
Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cells, Cultured; Cicatrix; Collagen; Drug Evaluation, Preclinical; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Humans; Indoles; Protein Kinase Inhibitors; Pyridones; Transforming Growth Factor beta1 | 2020 |
Potential treatment for vocal fold scar with pirfenidone.
Topics: Actins; Animals; Cells, Cultured; Cicatrix; Collagen Type I; Ferrets; Fibroblasts; Hyaluronan Synthases; Pyridones; Real-Time Polymerase Chain Reaction; Transforming Growth Factor beta1; Vocal Cords | 2018 |
Development of a Topical 48-H Release Formulation as an Anti-scarring Treatment for Deep Partial-Thickness Burns.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Burns; Cicatrix; Delayed-Action Preparations; Drug Liberation; Male; Mice; Mice, Inbred C57BL; Ointments; Pyridones; Treatment Outcome; Tumor Necrosis Factor-alpha; Wound Healing | 2018 |
Pirfenidone Ointment Modulates the Burn Wound Bed in C57BL/6 Mice by Suppressing Inflammatory Responses.
Topics: Actins; Animals; Burns; Cicatrix; Cytokines; Hydroxyproline; Inflammation; Mice; Mice, Inbred C57BL; Pyridones | 2019 |
Macrophage-secreted TGF-β
Topics: Animals; BALB 3T3 Cells; Cicatrix; Collagen; Constriction, Pathologic; Female; Fibroblasts; Macrophages; Mice; Models, Animal; Pyridones; RAW 264.7 Cells; Sus scrofa; Transforming Growth Factor beta1; Ureter; Ureteral Diseases; Wound Healing | 2019 |
Effect of pirfenidone injection on ferret vocal fold scars: A preliminary in vivo study.
Topics: Animals; Cicatrix; Ferrets; Injections, Intralesional; Laryngeal Diseases; Male; Pyridones; Vocal Cords | 2020 |
Pirfenidone inhibits fibrosis in foreign body reaction after glaucoma drainage device implantation.
Topics: Animals; Cicatrix; Disease Models, Animal; Fibrosis; Foreign-Body Reaction; Glaucoma Drainage Implants; Pyridones; Rabbits; Wound Healing | 2016 |
Scarred by disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cicatrix; Collagen; Fibrosis; Humans; Pyridones; Skin; United States; United States Food and Drug Administration | 2011 |
Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery.
Topics: Actins; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Cell Proliferation; Cicatrix; Collagen; Conjunctival Diseases; Disease Models, Animal; Drug Evaluation; Endothelium, Corneal; Glaucoma; Intraocular Pressure; Mitomycin; Ophthalmic Solutions; Postoperative Complications; Proliferating Cell Nuclear Antigen; Pyridones; Rabbits; Trabeculectomy; Tumor Necrosis Factor-alpha | 2011 |